 | • レポートコード：D0804-13213 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、135ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、チアネプチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。チアネプチンの種類別市場規模（特許、ジェネリック）、用途別市場規模（うつ病・不安、過敏性腸症候群）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Servier、Genefar B.V.、Antibiotice、Lupin Limited、Bausch Health、PharmaS、Glenmark、Alvogen、Serdia Pharmaceuticals、Arena Pharmaceuticals、Adamed、Novartis、Neuraxpharm Arzneimittel、Mylan、Dongwha Pharm、Grupo Insud、Liconsa SA ・地域別グローバル市場分析 2015年-2020年 ・チアネプチンの北米市場（アメリカ、カナダ、メキシコ） ・チアネプチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・チアネプチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・チアネプチンの南米市場（ブラジル、アルゼンチン） ・チアネプチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：特許、ジェネリック ・用途別分析：うつ病・不安、過敏性腸症候群 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Tianeptine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Tianeptine sales will be xx in 2020 from Tianeptine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Tianeptine market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Tianeptine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Tianeptine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Tianeptine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tianeptine market has been segmented into
Patent
Generic
By Application, Tianeptine has been segmented into:
Depression and Anxiety
Irritable Bowel Syndrome
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tianeptine market presented in the report. This section sheds light on the sales growth of different regional and country-level Tianeptine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tianeptine market.
The report offers in-depth assessment of the growth and other aspects of the Tianeptine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Tianeptine Market Share Analysis
Tianeptine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tianeptine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tianeptine sales, revenue and market share for each player covered in this report.
The major players covered in Tianeptine are:
Servier
Genefar B.V.
Antibiotice
Lupin Limited
Bausch Health
PharmaS
Glenmark
Alvogen
Serdia Pharmaceuticals
Arena Pharmaceuticals
Adamed
Novartis
Neuraxpharm Arzneimittel
Mylan
Dongwha Pharm
Grupo Insud
Liconsa SA
Among other players domestic and global, Tianeptine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tianeptine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tianeptine, with price, sales, revenue and global market share of Tianeptine in 2018 and 2019.
Chapter 3, the Tianeptine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tianeptine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Tianeptine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Tianeptine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Tianeptine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tianeptine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Patent
1.2.3 Generic
1.3 Market Analysis by Application
1.3.1 Overview: Global Tianeptine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Depression and Anxiety
1.3.3 Irritable Bowel Syndrome
1.4 Overview of Global Tianeptine Market
1.4.1 Global Tianeptine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Tianeptine Industry Impact
1.6.1 COVID-19 Potential Implications for the Tianeptine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Tianeptine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Servier
2.1.1 Servier Details
2.1.2 Servier Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Servier SWOT Analysis
2.1.4 Servier Product and Services
2.1.5 Servier Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genefar B.V.
2.2.1 Genefar B.V. Details
2.2.2 Genefar B.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genefar B.V. SWOT Analysis
2.2.4 Genefar B.V. Product and Services
2.2.5 Genefar B.V. Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Antibiotice
2.3.1 Antibiotice Details
2.3.2 Antibiotice Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Antibiotice SWOT Analysis
2.3.4 Antibiotice Product and Services
2.3.5 Antibiotice Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Lupin Limited
2.4.1 Lupin Limited Details
2.4.2 Lupin Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Lupin Limited SWOT Analysis
2.4.4 Lupin Limited Product and Services
2.4.5 Lupin Limited Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bausch Health SWOT Analysis
2.5.4 Bausch Health Product and Services
2.5.5 Bausch Health Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 PharmaS
2.6.1 PharmaS Details
2.6.2 PharmaS Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 PharmaS SWOT Analysis
2.6.4 PharmaS Product and Services
2.6.5 PharmaS Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Glenmark
2.7.1 Glenmark Details
2.7.2 Glenmark Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Glenmark SWOT Analysis
2.7.4 Glenmark Product and Services
2.7.5 Glenmark Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Alvogen
2.8.1 Alvogen Details
2.8.2 Alvogen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Alvogen SWOT Analysis
2.8.4 Alvogen Product and Services
2.8.5 Alvogen Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Serdia Pharmaceuticals
2.9.1 Serdia Pharmaceuticals Details
2.9.2 Serdia Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Serdia Pharmaceuticals SWOT Analysis
2.9.4 Serdia Pharmaceuticals Product and Services
2.9.5 Serdia Pharmaceuticals Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Arena Pharmaceuticals
2.10.1 Arena Pharmaceuticals Details
2.10.2 Arena Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Arena Pharmaceuticals SWOT Analysis
2.10.4 Arena Pharmaceuticals Product and Services
2.10.5 Arena Pharmaceuticals Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Adamed
2.11.1 Adamed Details
2.11.2 Adamed Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Adamed SWOT Analysis
2.11.4 Adamed Product and Services
2.11.5 Adamed Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Novartis
2.12.1 Novartis Details
2.12.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Novartis SWOT Analysis
2.12.4 Novartis Product and Services
2.12.5 Novartis Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Neuraxpharm Arzneimittel
2.13.1 Neuraxpharm Arzneimittel Details
2.13.2 Neuraxpharm Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Neuraxpharm Arzneimittel SWOT Analysis
2.13.4 Neuraxpharm Arzneimittel Product and Services
2.13.5 Neuraxpharm Arzneimittel Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Mylan
2.14.1 Mylan Details
2.14.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Mylan SWOT Analysis
2.14.4 Mylan Product and Services
2.14.5 Mylan Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Dongwha Pharm
2.15.1 Dongwha Pharm Details
2.15.2 Dongwha Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Dongwha Pharm SWOT Analysis
2.15.4 Dongwha Pharm Product and Services
2.15.5 Dongwha Pharm Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Grupo Insud
2.16.1 Grupo Insud Details
2.16.2 Grupo Insud Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Grupo Insud SWOT Analysis
2.16.4 Grupo Insud Product and Services
2.16.5 Grupo Insud Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Liconsa SA
2.17.1 Liconsa SA Details
2.17.2 Liconsa SA Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Liconsa SA SWOT Analysis
2.17.4 Liconsa SA Product and Services
2.17.5 Liconsa SA Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Tianeptine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Tianeptine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Tianeptine Manufacturer Market Share in 2019
3.3.2 Top 6 Tianeptine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Tianeptine Sales, Revenue and Market Share by Regions
4.1.1 Global Tianeptine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Tianeptine Revenue and Market Share by Regions (2015-2020)
4.2 North America Tianeptine Sales and Growth Rate (2015-2020)
4.3 Europe Tianeptine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Tianeptine Sales and Growth Rate (2015-2020)
4.5 South America Tianeptine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Tianeptine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Tianeptine Sales, Revenue and Market Share by Country
5.1.1 North America Tianeptine Sales and Market Share by Country (2015-2020)
5.1.2 North America Tianeptine Revenue and Market Share by Country (2015-2020)
5.2 United States Tianeptine Sales and Growth Rate (2015-2020)
5.3 Canada Tianeptine Sales and Growth Rate (2015-2020)
5.4 Mexico Tianeptine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Tianeptine Sales, Revenue and Market Share by Country
6.1.1 Europe Tianeptine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Tianeptine Revenue and Market Share by Country (2015-2020)
6.2 Germany Tianeptine Sales and Growth Rate (2015-2020)
6.3 UK Tianeptine Sales and Growth Rate (2015-2020)
6.4 France Tianeptine Sales and Growth Rate (2015-2020)
6.5 Russia Tianeptine Sales and Growth Rate (2015-2020)
6.6 Italy Tianeptine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Tianeptine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Tianeptine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Tianeptine Revenue and Market Share by Regions (2015-2020)
7.2 China Tianeptine Sales and Growth Rate (2015-2020)
7.3 Japan Tianeptine Sales and Growth Rate (2015-2020)
7.4 Korea Tianeptine Sales and Growth Rate (2015-2020)
7.5 India Tianeptine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Tianeptine Sales and Growth Rate (2015-2020)
7.7 Australia Tianeptine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Tianeptine Sales, Revenue and Market Share by Country
8.1.1 South America Tianeptine Sales and Market Share by Country (2015-2020)
8.1.2 South America Tianeptine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Tianeptine Sales and Growth Rate (2015-2020)
8.3 Argentina Tianeptine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Tianeptine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Tianeptine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Tianeptine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Tianeptine Sales and Growth Rate (2015-2020)
9.3 Turkey Tianeptine Sales and Growth Rate (2015-2020)
9.4 Egypt Tianeptine Sales and Growth Rate (2015-2020)
9.5 South Africa Tianeptine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Tianeptine Sales and Market Share by Type (2015-2020)
10.2 Global Tianeptine Revenue and Market Share by Type (2015-2020)
10.3 Global Tianeptine Price by Type (2015-2020)
11 Global Tianeptine Market Segment by Application
11.1 Global Tianeptine Sales Market Share by Application (2015-2020)
11.2 Global Tianeptine Revenue Market Share by Application (2015-2020)
11.3 Global Tianeptine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Tianeptine Sales, Revenue and Growth Rate (2021-2025)
12.2 Tianeptine Market Forecast by Regions (2021-2025)
12.2.1 North America Tianeptine Market Forecast (2021-2025)
12.2.2 Europe Tianeptine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Tianeptine Market Forecast (2021-2025)
12.2.4 South America Tianeptine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Tianeptine Market Forecast (2021-2025)
12.3 Tianeptine Market Forecast by Type (2021-2025)
12.3.1 Global Tianeptine Sales Forecast by Type (2021-2025)
12.3.2 Global Tianeptine Market Share Forecast by Type (2021-2025)
12.4 Tianeptine Market Forecast by Application (2021-2025)
12.4.1 Global Tianeptine Sales Forecast by Application (2021-2025)
12.4.2 Global Tianeptine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Tianeptine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tianeptine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tianeptine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Tianeptine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Servier Basic Information, Manufacturing Base and Competitors
Table 9. Servier Tianeptine Major Business
Table 10. Servier Tianeptine Total Revenue (USD Million) (2018-2019)
Table 11. Servier SWOT Analysis
Table 12. Servier Tianeptine Product and Services
Table 13. Servier Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Genefar B.V. Basic Information, Manufacturing Base and Competitors
Table 15. Genefar B.V. Tianeptine Major Business
Table 16. Genefar B.V. Tianeptine Total Revenue (USD Million) (2018-2019)
Table 17. Genefar B.V. SWOT Analysis
Table 18. Genefar B.V. Tianeptine Product and Services
Table 19. Genefar B.V. Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Antibiotice Basic Information, Manufacturing Base and Competitors
Table 21. Antibiotice Tianeptine Major Business
Table 22. Antibiotice Tianeptine Total Revenue (USD Million) (2018-2019)
Table 23. Antibiotice SWOT Analysis
Table 24. Antibiotice Tianeptine Product and Services
Table 25. Antibiotice Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Lupin Limited Basic Information, Manufacturing Base and Competitors
Table 27. Lupin Limited Tianeptine Major Business
Table 28. Lupin Limited Tianeptine Total Revenue (USD Million) (2018-2019)
Table 29. Lupin Limited SWOT Analysis
Table 30. Lupin Limited Tianeptine Product and Services
Table 31. Lupin Limited Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 33. Bausch Health Tianeptine Major Business
Table 34. Bausch Health Tianeptine Total Revenue (USD Million) (2018-2019)
Table 35. Bausch Health SWOT Analysis
Table 36. Bausch Health Tianeptine Product and Services
Table 37. Bausch Health Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. PharmaS Basic Information, Manufacturing Base and Competitors
Table 39. PharmaS Tianeptine Major Business
Table 40. PharmaS Tianeptine Total Revenue (USD Million) (2018-2019)
Table 41. PharmaS SWOT Analysis
Table 42. PharmaS Tianeptine Product and Services
Table 43. PharmaS Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Glenmark Basic Information, Manufacturing Base and Competitors
Table 45. Glenmark Tianeptine Major Business
Table 46. Glenmark Tianeptine Total Revenue (USD Million) (2018-2019)
Table 47. Glenmark SWOT Analysis
Table 48. Glenmark Tianeptine Product and Services
Table 49. Glenmark Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Alvogen Basic Information, Manufacturing Base and Competitors
Table 51. Alvogen Tianeptine Major Business
Table 52. Alvogen Tianeptine Total Revenue (USD Million) (2018-2019)
Table 53. Alvogen SWOT Analysis
Table 54. Alvogen Tianeptine Product and Services
Table 55. Alvogen Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Serdia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 57. Serdia Pharmaceuticals Tianeptine Major Business
Table 58. Serdia Pharmaceuticals Tianeptine Total Revenue (USD Million) (2018-2019)
Table 59. Serdia Pharmaceuticals SWOT Analysis
Table 60. Serdia Pharmaceuticals Tianeptine Product and Services
Table 61. Serdia Pharmaceuticals Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 63. Arena Pharmaceuticals Tianeptine Major Business
Table 64. Arena Pharmaceuticals Tianeptine Total Revenue (USD Million) (2018-2019)
Table 65. Arena Pharmaceuticals SWOT Analysis
Table 66. Arena Pharmaceuticals Tianeptine Product and Services
Table 67. Arena Pharmaceuticals Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Adamed Basic Information, Manufacturing Base and Competitors
Table 69. Adamed Tianeptine Major Business
Table 70. Adamed Tianeptine Total Revenue (USD Million) (2018-2019)
Table 71. Adamed SWOT Analysis
Table 72. Adamed Tianeptine Product and Services
Table 73. Adamed Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Novartis Basic Information, Manufacturing Base and Competitors
Table 75. Novartis Tianeptine Major Business
Table 76. Novartis Tianeptine Total Revenue (USD Million) (2018-2019)
Table 77. Novartis SWOT Analysis
Table 78. Novartis Tianeptine Product and Services
Table 79. Novartis Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Neuraxpharm Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 81. Neuraxpharm Arzneimittel Tianeptine Major Business
Table 82. Neuraxpharm Arzneimittel Tianeptine Total Revenue (USD Million) (2018-2019)
Table 83. Neuraxpharm Arzneimittel SWOT Analysis
Table 84. Neuraxpharm Arzneimittel Tianeptine Product and Services
Table 85. Neuraxpharm Arzneimittel Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Mylan Basic Information, Manufacturing Base and Competitors
Table 87. Mylan Tianeptine Major Business
Table 88. Mylan Tianeptine Total Revenue (USD Million) (2018-2019)
Table 89. Mylan SWOT Analysis
Table 90. Mylan Tianeptine Product and Services
Table 91. Mylan Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Dongwha Pharm Basic Information, Manufacturing Base and Competitors
Table 93. Dongwha Pharm Tianeptine Major Business
Table 94. Dongwha Pharm Tianeptine Total Revenue (USD Million) (2018-2019)
Table 95. Dongwha Pharm SWOT Analysis
Table 96. Dongwha Pharm Tianeptine Product and Services
Table 97. Dongwha Pharm Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Grupo Insud Basic Information, Manufacturing Base and Competitors
Table 99. Grupo Insud Tianeptine Major Business
Table 100. Grupo Insud Tianeptine Total Revenue (USD Million) (2018-2019)
Table 101. Grupo Insud SWOT Analysis
Table 102. Grupo Insud Tianeptine Product and Services
Table 103. Grupo Insud Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Liconsa SA Basic Information, Manufacturing Base and Competitors
Table 105. Liconsa SA Tianeptine Major Business
Table 106. Liconsa SA Tianeptine Total Revenue (USD Million) (2018-2019)
Table 107. Liconsa SA SWOT Analysis
Table 108. Liconsa SA Tianeptine Product and Services
Table 109. Liconsa SA Tianeptine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Global Tianeptine Sales by Manufacturer (2018-2019) (K Units)
Table 111. Global Tianeptine Revenue by Manufacturer (2018-2019) (USD Million)
Table 112. Global Tianeptine Sales by Regions (2015-2020) (K Units)
Table 113. Global Tianeptine Sales Market Share by Regions (2015-2020)
Table 114. Global Tianeptine Revenue by Regions (2015-2020) (USD Million)
Table 115. North America Tianeptine Sales by Countries (2015-2020) (K Units)
Table 116. North America Tianeptine Sales Market Share by Countries (2015-2020)
Table 117. North America Tianeptine Revenue by Countries (2015-2020) (USD Million)
Table 118. North America Tianeptine Revenue Market Share by Countries (2015-2020)
Table 119. Europe Tianeptine Sales by Countries (2015-2020) (K Units)
Table 120. Europe Tianeptine Sales Market Share by Countries (2015-2020)
Table 121. Europe Tianeptine Revenue by Countries (2015-2020) (USD Million)
Table 122. Asia-Pacific Tianeptine Sales by Regions (2015-2020) (K Units)
Table 123. Asia-Pacific Tianeptine Sales Market Share by Regions (2015-2020)
Table 124. Asia-Pacific Tianeptine Revenue by Regions (2015-2020) (USD Million)
Table 125. South America Tianeptine Sales by Countries (2015-2020) (K Units)
Table 126. South America Tianeptine Sales Market Share by Countries (2015-2020)
Table 127. South America Tianeptine Revenue by Countries (2015-2020) (USD Million)
Table 128. South America Tianeptine Revenue Market Share by Countries (2015-2020)
Table 129. Middle East & Africa Tianeptine Sales by Countries (2015-2020) (K Units)
Table 130. Middle East & Africa Tianeptine Sales Market Share by Countries (2015-2020)
Table 131. Middle East & Africa Tianeptine Revenue by Countries (2015-2020) (USD Million)
Table 132. Middle East & Africa Tianeptine Revenue Market Share by Countries (2015-2020)
Table 133. Global Tianeptine Sales by Type (2015-2020) (K Units)
Table 134. Global Tianeptine Sales Share by Type (2015-2020)
Table 135. Global Tianeptine Revenue by Type (2015-2020) (USD Million)
Table 136. Global Tianeptine Revenue Share by Type (2015-2020)
Table 137. Global Tianeptine Sales by Application (2015-2020) (K Units)
Table 138. Global Tianeptine Sales Share by Application (2015-2020)
Table 139. Global Tianeptine Sales Forecast by Regions (2021-2025) (K Units)
Table 140. Global Tianeptine Market Share Forecast by Regions (2021-2025)
Table 141. Global Tianeptine Sales Forecast by Type (2021-2025) (K Units)
Table 142. Global Tianeptine Market Share Forecast by Type (2021-2025)
Table 143. Global Tianeptine Sales Forecast by Application (2021-2025)
Table 144. Global Tianeptine Market Share Forecast by Application (2021-2025)
Table 145. Direct Channel Pros & Cons
Table 146. Indirect Channel Pros & Cons
Table 147. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Tianeptine Picture
Figure 2. Global Sales Market Share of Tianeptine by Type in 2019
Figure 3. Patent Picture
Figure 4. Generic Picture
Figure 5. Tianeptine Sales Market Share by Application in 2018
Figure 6. Depression and Anxiety Picture
Figure 7. Irritable Bowel Syndrome Picture
Figure 8. Global Tianeptine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Tianeptine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Tianeptine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Tianeptine Sales Market Share by Manufacturer in 2019
Figure 29. Global Tianeptine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Tianeptine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Tianeptine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Tianeptine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Tianeptine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Tianeptine Revenue Market Share by Regions in 2018
Figure 37. North America Tianeptine Sales and Growth Rate (2015-2020)
Figure 38. Europe Tianeptine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Tianeptine Sales and Growth Rate (2015-2020)
Figure 40. South America Tianeptine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Tianeptine Sales and Growth Rate (2015-2020)
Figure 42. North America Tianeptine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Tianeptine Sales Market Share by Countries (2015-2020)
Figure 44. North America Tianeptine Sales Market Share by Countries in 2018
Figure 45. North America Tianeptine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Tianeptine Revenue Market Share by Countries in 2018
Figure 47. United States Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Tianeptine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Tianeptine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Tianeptine Revenue Market Share by Countries in 2019
Figure 53. Germany Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Tianeptine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Tianeptine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Tianeptine Revenue Market Share by Regions 2019
Figure 61. China Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Tianeptine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Tianeptine Sales Market Share by Countries in 2019
Figure 68. South America Tianeptine Revenue Market Share by Countries in 2019
Figure 69. Brazil Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Tianeptine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Tianeptine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Tianeptine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Tianeptine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Tianeptine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Tianeptine Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Tianeptine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Tianeptine Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Tianeptine Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Tianeptine Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Tianeptine Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Tianeptine Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
ブルガダ症候群の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Brugada Syndrome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…- 非薬物療法うつ病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Drug Free Depression Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug Free Depr…
- レストレスレッグス症候群の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Restless Legs Syndrome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Restless Legs Syndrome…
- 不安障害治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anxiety Disorders Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 不安障害治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anxiety Disorders Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…